Case report review highlights suspicion of breast cancer metastasis to thyroid in a 54-year-old woman
Breast cancer can spread to the thyroid gland in rare cases
This case report review describes a 54-year-old woman with a history of breast cancer who developed metastasis to the thyroid. The authors n…
A single case report shows a 54-year-old woman survived after breast cancer spread to her thyroid, highlighting the need for careful diagnos…
Meta-analysis reveals complex links between endocrine therapy and fertility worries in cancer patients of childbearing age
Depression and endocrine therapy linked to fertility worries in cancer patients of childbearing age
A systematic review of 3,282 patients found depression, higher education, and endocrine therapy linked to fertility concerns. Conversely, ma…
A review of 3282 cancer patients found depression, endocrine therapy, and full-time work linked to fertility concerns, while marriage and ha…
Receptor discordance in metastatic breast cancer lesions associated with poorer overall survival in a retrospective cohort study
When breast cancer changes its targets, does the current treatment still work?
This single-center retrospective cohort study analyzed 436 paired lesion samples from patients with primary and metastatic breast cancer.
Breast cancer often changes its targets, and when tumors lose the proteins doctors rely on, survival drops from 95 to 70 months depending on…
Case report describes embolization and endocrine therapy for post-biopsy hematoma in prostate cancer patient
A Rare Bruise After Prostate Biopsy — What Every Man Should Know
A case report and literature review describes a prostate cancer patient who developed extensive subcutaneous hematoma after transperineal pr…
Large bruising after prostate biopsy is uncommon, but knowing how it looks can get treatment started quickly.
Sequential paclitaxel-palbociclib showed no difference in ORR versus reverse sequence in ER+/HER2- breast cancer
New Test Predicts Who Needs Chemo in Breast Cancer
This randomized phase II trial evaluated sequential administration of paclitaxel and palbociclib with endocrine therapy in patients with ER+…
Doctors now have a way to spot patients who can skip chemo and go straight to safer hormone treatment.